![](/img/cover-not-exists.png)
Phase II, Open Label, Randomized Comparative Trial of Ondansetron Alone versus the Combination of Ondansetron and Aprepitant for the Prevention of Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Regimens Containing High-Dose Cytarabine
Badar, Talha, Cortes, Jorge, Borthakur, Gautam, O’Brien, Susan, Wierda, William, Garcia-Manero, Guillermo, Ferrajoli, Alessandra, Kadia, Tapan, Poku, Rebeca, Kantarjian, Hagop, Mattiuzzi, GloriaVolume:
2015
Year:
2015
Language:
english
Journal:
BioMed Research International
DOI:
10.1155/2015/497597
File:
PDF, 1.26 MB
english, 2015